Privia Health (PRVA)

• Market cap: $2.67B
• 1 day: 1.78%
• 5 days: 8.07%
• 1 month: 6.97%
• 3 months: 20.61%
• 6 months: 14.99%
• Year to date: 13.24%
• 1 year: 6.31%
• 5 years: -36.00%
• 10 years: -36.00%
• Sector: Healthcare
• Industry: Health Services

About: Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Employees: 1,102

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

2,256% more call options, than puts

Call options by funds: $4.97M | Put options by funds: $211K

35% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 23

5% more capital invested

Capital invested by funds: $2.07B [Q2] → $2.18B (+$113M) [Q3]

3% more funds holding

Funds holding: 226 [Q2] → 232 (+6) [Q3]

0.48% more ownership

Funds ownership: 99.75% [Q2] → 100.23% (+0.48%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

13% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 89

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 6% downside
• Avg. target: $25 14% upside
• High target: $28 26% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

Needham Ryan MacDonald 56% 1-year accuracy 38 / 68 met price target	12% upside $25	Buy Reiterated	15 Jan 2025
Needham Matthew Sheerin 58% 1-year accuracy 15 / 26 met price target	12% upside $25	Buy Initiated	10 Jan 2025
Stephens & Co. Jeff Garro 50% 1-year accuracy 3 / 6 met price target	17% upside $26	Overweight Reiterated	7 Jan 2025
Macquarie Tao Qiu 38% 1-year accuracy 6 / 16 met price target	12% upside $25	Outperform Initiated	16 Dec 2024
JP Morgan Lisa Gill 50% 1-year accuracy 10 / 20 met price target	26% upside $28	Overweight Maintained	29 Nov 2024